<?xml version="1.0" encoding="UTF-8"?>
<p>The immune response after vaccination with the mumps vaccine (containing Urabe strain) has been studied in developing countries. A lower antigen response was found in subjects with measles and mumps vaccination for a nine-month-old group than for a 12â€“15-month-old group in India [
 <xref rid="B110-ijerph-17-01686" ref-type="bibr">110</xref>]. Among children aged 12 months, the immunogenicity response rate was 98% in Taiwan [
 <xref rid="B111-ijerph-17-01686" ref-type="bibr">111</xref>] and 92% in India [
 <xref rid="B110-ijerph-17-01686" ref-type="bibr">110</xref>]. In the United Kingdom, a study showed that the seropositivity rates were 85% at 4 years after a single dose of MMR vaccination with the Urabe strain vaccine, compared with 81% for vaccination with the Jeryl Lynn strain [
 <xref rid="B112-ijerph-17-01686" ref-type="bibr">112</xref>]. In Canada, a study found that five to six years after one dose of MMR vaccine, the seropositivity rate was 93% for the Urabe strain, compared with 85% for the Jeryl Lynn strain [
 <xref rid="B113-ijerph-17-01686" ref-type="bibr">113</xref>,
 <xref rid="B114-ijerph-17-01686" ref-type="bibr">114</xref>,
 <xref rid="B115-ijerph-17-01686" ref-type="bibr">115</xref>].
</p>
